Phase 2 Vitiligo Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are an adult between 18 and 65 years old and are able to give your own consent to participate.
- You have been diagnosed with nonsegmental vitiligo (a common form where patches appear in a scattered pattern) that has been stable — meaning no new patches and no existing patches getting bigger — for at least 6 months before the screening visit.
- Your vitiligo affects between 3% and 20% of your total body surface area, and you have at least two patches that can be clearly measured and photographed.
- You are willing to receive a specific type of light therapy called NB-UVB as part of the study, and to stop using other vitiligo treatments during the trial.
- If you are someone who could become pregnant, you agree to use effective birth control throughout the study and for a set period after your last dose.
Who may not be able to join:
- Your vitiligo is mainly the segmental type (patches on one side of the body) or your condition has been getting worse quickly in the past 6 months.
- You have taken certain medicines that affect the immune system — such as immunosuppressants, steroid tablets, or JAK inhibitor drugs — within the past 8 weeks (the exact timeframe may depend on the specific medicine).
- You have applied certain skin creams (calcineurin inhibitors or steroid creams) to the patches being studied within the past 2 weeks.
- You have previously been treated with afamelanotide or melanotan (including Melanotan II) within the past 6 months.
- You have a history of melanoma, a condition called dysplastic nevus syndrome, or other serious skin cancers that need close monitoring, as decided by the study doctor.
- You have significantly uncontrolled high blood pressure, heart or blood vessel disease, or any other health condition that the study doctor believes could put you at higher risk with this type of treatment.
- You are currently pregnant or breastfeeding.
- You have a known allergy or sensitivity to any ingredients in the study treatment.
- You have taken part in another clinical trial involving a treatment within the past 30 days before your screening visit.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 13076790030
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in Vitiligo Area Scoring Index (VASI) total score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.